50 % of patients involved in clinical trials do not take their medication as prescribed, resulting in underestimated drug efficacy and delayed approval of the investigational product.
Poor medication adherence is thus a threat to drug development.
Stop using unreliable methods to assess medication adherence and maximize the chances of success in your clinical trials by using an evidence-based digital adherence monitoring system.
Find more news here.
Imagine spending years developing a promising new treatment, only to have its potential clouded by something as simple (and as overlooked) as whether or not people actually took their pills. This isn’t just a small glitch in the process. In
You’ll often hear the terms “adherence” and “compliance” used as if they mean the same thing. But in healthcare and clinical research, they carry very different meanings. Understanding that difference can change the way we work with patients, design better